Related Experiment Video

Updated: May 10, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

Endothelial progenitor cells and long-term prognosis in patients with stable angina treated with percutaneous

Micha Chyrchel1, Tomasz Rakowski, Andrzej Surdacki

  • 12nd Department of Cardiology, Jagiellonian University.

Circulation Journal : Official Journal of the Japanese Circulation Society
|July 2, 2013
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
08:43

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

Related Experiment Videos

Last Updated: May 10, 2026

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
08:43

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...

Articles linked to this work by shared authors, journal, and citation graph.

Temporal trends and clinical characteristics of drug-coated balloon angioplasty for de novo coronary lesions: A 6-year analysis from the ORPKI registry.

American heart journal·2026

Long-term prognosis in patients suffering from myocardial infarction with non-obstructive coronary arteries, ST-segment elevation myocardial infarction, infective myocarditis and tako-tsubo cardiomyopathy - all-cause mortality comparison.

Archives of medical science : AMS·2026

Acute Stent Thrombosis During Glycoprotein IIb/IIIa Inhibitor Infusion.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026

Circadian variation in ST-segment elevation myocardial infarction: a nationwide analysis of onset, treatment delays, and culprit artery patterns.

Polish archives of internal medicine·2026

Pathogenesis of Acute Coronary Syndromes in Patients After COVID-19: An Optical Coherence Tomography Study.

Journal of clinical medicine·2025

The Irreversible March of Time: Ischemic Delay and Impact on Outcomes in ST-Segment Elevation Myocardial Infarction.

Journal of cardiovascular development and disease·2025

Reduced Adverse Events Without Survival Benefit With HeartMate 3 vs. HeartMate II in Japan.

Circulation journal : official journal of the Japanese Circulation Society·2026

High Lipoprotein(a) Is a Predictor of Adverse Events and Heart Failure in Patients With Acute Myocardial Infarction.

Circulation journal : official journal of the Japanese Circulation Society·2026

Nationwide Evolution of Durable Left Ventricular Assist Device Outcomes Following Introduction of the HeartMate 3 and Destination Therapy in Japan - The Third Official Report From J-MACS.

Circulation journal : official journal of the Japanese Circulation Society·2026

Phenotyping Heart Failure With Preserved Ejection Fraction in Japan - Position Paper on Current Evidence and Future Directions.

Circulation journal : official journal of the Japanese Circulation Society·2026

Prognostic Impact of Left Ventricular Apical Aneurysm Identified by Echocardiography in Hypertrophic Cardiomyopathy - A Multicenter Retrospective Study in Japan.

Circulation journal : official journal of the Japanese Circulation Society·2026

In-Hospital Guideline-Directed Medical Therapy Intensification and Long-Term Outcomes in Patients Hospitalized for Heart Failure in the Current Clinical Paradigm - Insights From the QHEART-R Study.

Circulation journal : official journal of the Japanese Circulation Society·2026

Correction: Implementation of guideline-recommended organ-protective therapy in people with type 2 diabetes and cardiovascular disease, heart failure, or kidney disease: real-world evidence from a German University Hospital.

Frontiers in endocrinology·2026

Integration of hereditary thrombophilia data and polygenic risk scores into prognostic models improves differential diagnosis of CTEPH.

Frontiers in cardiovascular medicine·2026

Hybutimibe, an innovative cholesterol absorption inhibitor for lipid-lowering therapy: current evidence and future perspectives.

Frontiers in pharmacology·2026

Beyond traditional anticoagulants: exploring the future of thromboembolism treatment with FXI inhibitors.

Frontiers in immunology·2026

Living with angina: rethinking angina management in ANOCA through lived experience.

Frontiers in cardiovascular medicine·2026

Association of early neutrophil-to-lymphocyte ratio trajectories with cardiac recovery and live ICU discharge in patients with sepsis-induced cardiomyopathy: a retrospective cohort study.

Frontiers in medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us